about
Novartis develops and manufactures innovative drugs. Key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the ...
Read More
143.58
-0.76
(-0.53%)
1.8M
XNYS Volume
XNYS 20 Jan, 2026 4:30 PM (EST)
Board Meeting
The next board meeting for Novartis AG (ADR) is on 30 Jan 2026 for the purpose of Novartis AG Fourth Quarter Earnings Results for 2025
See details
High Financial Strength
Mid Valuation
Technically Moderately Bullish
Strong Performer, Getting Expensive
These stocks are strong in quality and technicals but have medium valuation. At somewhat expensive valuations, investors should be cautious before buying
View Similar
Embed DVM
Novartis AG (ADR) Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..